{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:30:56Z","timestamp":1659112256874},"reference-count":22,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.lpm.2011.03.012","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T17:20:39Z","timestamp":1309540839000},"page":"e333-e337","source":"Crossref","is-referenced-by-count":4,"title":["Les antagonistes de l\u2019interleukine-6 (tocilizumab) dans la maladie de still r\u00e9fractaire de l\u2019adulte"],"prefix":"10.1016","volume":"40","author":[{"given":"Youssef","family":"Sekkach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elqatni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdessadek El","family":"Khattabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Fatihi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salaheddine","family":"Hammi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Badaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoual","family":"Elomri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadoua","family":"Mekouar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taoufik","family":"Amezyane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abouzahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Driss","family":"Ghafir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2011.03.012_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2011.03.012_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still's disease","volume":"63","author":"Pu\u00e9chal","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lpm.2011.03.012_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0248-8663(01)00549-5","article-title":"Peut-on encore parler de syndrome de Wissler-Fanconi\u00a0?","volume":"23","author":"Pouchot","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2011.03.012_bib0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset Still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2011.03.012_bib0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/rheumatology\/41.2.216","article-title":"Miller Fisher syndrome in adult onset Still's disease: case report and review of the literature of other neurological manifestations","volume":"41","author":"Desai","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.lpm.2011.03.012_bib0030","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease","volume":"28","author":"Fautrel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0035","first-page":"412","article-title":"Serum ferritin can be useful for diagnosis in adult onset Still's disease","volume":"16","author":"Gonzalez-Hernandez","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1\u00a0receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still\u2019disease. Preliminary experience in France","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2011.03.012_bib0045","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1136\/ard.59.suppl_1.i21","article-title":"Anti-interleukin 6\u00a0receptor antibody treatment in rheumatic disease","volume":"59","author":"Nishimoto","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2011.03.012_bib0050","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0248-8663(05)81400-6","article-title":"Complications cardiaques de la maladie de Still de l\u2019adulte\u00a0: de la p\u00e9ricardite \u00e0 la tamponade parfois r\u00e9v\u00e9latrice","volume":"15","author":"Drouot","year":"1994","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.lpm.2011.03.012_bib0060","first-page":"698","article-title":"Meningoencephalitis and peripheral neuropathy complicating adult Still's disease","volume":"17","author":"Denault","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0065","first-page":"1139","article-title":"Adult Still's disease: review of 228\u00a0cases from the literature","volume":"14","author":"Ohta","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/520170","article-title":"Aseptic meningitis and cranial nerve palsy revealing adultonset Still's disease","volume":"29","author":"Marie","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lpm.2011.03.012_bib0075","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.lpm.2009.02.006","article-title":"Anti-TNFalpha therapy in systemic autoimmune and\/or inflammatory diseases","volume":"38","author":"R\u00e9gent","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2011.03.012_bib0080","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adultonset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2011.03.012_bib0085","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1186\/ar1826","volume":"7","author":"Woo","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2011.03.012_bib0090","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.10620","article-title":"Humanized monoclonal antiinterleukin-6\u00a0receptor antibody for treatment of intractable adult-onset Still's disease","volume":"46","author":"Iwamoto","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2011.03.012_bib0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10067-009-1097-z","article-title":"Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with Tocilizumab","volume":"28","author":"Matsumoto","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","article-title":"Clinical value of blocking IL-6\u00a0receptor","volume":"21","author":"Mima","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/s10165-008-0116-2","article-title":"A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6\u00a0years","volume":"16","author":"Nakahara","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.lpm.2011.03.012_bib0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ard.2008.088179","article-title":"Tocilizumab for multirefractory adult-onset Still's disease","volume":"68","author":"Bandt","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498211002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T18:56:44Z","timestamp":1543690604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498211002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":22,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0755498211002120"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2011.03.012","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}